REVIUM Rx. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
REVIUM Rx. (RVRC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 11.33 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-03-31
- REVIUM Rx. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 11.33M shares, a 0.00% change from fiscal 2024.
- REVIUM Rx. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 11.33M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|
| 2025-12-31 | 11.33M shares 10-K · filed 2026-03-31 |
| 2024-12-31 | 11.33M shares 10-K · filed 2026-03-31 |